The treatment of Cholestasis & Eye Health with vitamins

Cholestasis and Eye Health: Mitamins custom make quality formulas for the treatment of Cholestasis & Eye Health with vitamins. A Cholestasis & Eye Health formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Cholestasis and Eye Health

  • Amount Per Serving
    % DV
    Vitamin A
    2500
    IU
    50%
    Vitamin C
    100
    mg
    167%
    Vitamin E
    200
    IU
    667%
    Vitamin K
    10
    mcg
    13%
    Lutein
    1000
    mcg
    *
    SAMe
    400
    mg
    *
    Bilberry Extract
    50
    mg
    *
  • Amount Per Serving
    % DV
    Bioflavonoid Concentrate
    50
    mg
    *
    Milk Thistle Extract
    100
    mg
    *
    N-Acetyl L-Cysteine
    100
    mg
    *
    L-Glutamine
    100
    mg
    *
    Amino Acid Mix
    50
    mg
    *
    Dandelion Extract
    100
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice

Cholestasis and Eye Health Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Tysabri® Demonstrates Significant Health-Related Quality Of Life Improvements For Multiple Sclerosis Patients
Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced today the publication of results demonstrating that patients treated with TYSABRI® (natalizumab) showed a significant improvement in health-related quality of life (HRQoL) measures when compared to placebo. These results are from the first Phase III multiple sclerosis (MS) studies that have demonstrated improvement on HRQoL measures in patients with relapsing forms of MS.
FDA Issues Second Approvable Letter For Trexima?
GlaxoSmithKline (LSE & NYSE: GSK) and POZEN Inc. (NASDAQ: POZN) today announced that the U.S. Food and Drug Administration (FDA) has issued a second approvable letter for Trexima? (sumatriptan/naproxen sodium). An approvable letter is an official notification from the FDA that contains conditions that must be satisfied prior to obtaining final U.S.marketing approval.
This information concerning the support of Cholestasis and Eye Health treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments